1. Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers
- Author
-
Nieto, Steven J, Venegas, Alexandra, Burnette, Elizabeth M, MacKillop, James, and Ray, Lara A
- Subjects
Biological Psychology ,Psychology ,Clinical Trials and Supportive Activities ,Tobacco Smoke and Health ,Brain Disorders ,Tobacco ,Substance Misuse ,Alcoholism ,Alcohol Use and Health ,Clinical Research ,Cardiovascular ,Mental health ,Cancer ,Good Health and Well Being ,Alcohol Drinking ,Alcoholic Intoxication ,Alcoholism ,Cannabis ,Delay Discounting ,Ethanol ,Hallucinogens ,Humans ,Substance-Related Disorders ,Tobacco Products ,Delay discounting ,Alcohol ,Alcohol use disorder ,Decision-making ,Behavioral economics ,Co-use ,Polysubstance use ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Psychiatry ,Biological psychology - Abstract
RationaleAlcohol use disorder (AUD) is associated with steeper delay discounting rates; however, it is unknown whether substance co-use, particularly cannabis use, has an additive effect on discounting rates among heavy drinkers. Furthermore, it is unclear whether substance co-use and delay discounting are independently associated with AUD severity.ObjectivesThe purpose of this study was to determine whether alcohol, tobacco, and cannabis co-use impacts delay discounting rates. We also sought to determine whether substance co-use and delay discounting were associated with AUD symptom counts.MethodsThe study sample was culled from several human laboratory studies and consisted of 483 heavy drinking individuals who completed a baseline visit (prior to experimental procedures). Participants were divided into groups based on self-reported alcohol, tobacco, and cannabis use during the past 30 days: alcohol only (n = 184), alcohol + cigarettes (n = 89), alcohol + cannabis (n = 82), and tri-use (n = 128). We examined discounting rates across the 4 groups and used multiple linear regression to test whether co-use and delay discounting were associated with AUD symptoms.ResultsAfter adjusting for covariates, individuals in the alcohol + cannabis group and the tri-use group had steeper discounting rates relative to the alcohol-only group. In addition, tri-use and delay discounting rates were independently correlated with a greater number of AUD symptoms.ConclusionsDelay discounting rates were significantly greater among subgroups reporting cannabis use providing partial support for an additive effect, while also highlighting the importance of co-use substance type. Both tri-use and delay discounting were associated with greater AUD severity, which may provide relevant intervention targets.
- Published
- 2022